TETRAPHASE PHARMACEUTICALS I

CUSIP: 88165N105 Class: COMMON STOCK

GOLDMAN SACHS GROUP INC's Holding History (CIK: 0000886982)

Note: Option positions (PUT/CALL) are excluded.

Q2 2019
Shares 380,978 Value ($000) $183 Avg Close — Range —
Q1 2019
Shares 127,580 Value ($000) $171 Avg Close — Range —
Q4 2018
Shares 206,502 Value ($000) $233 Avg Close — Range —
Q3 2018
Shares 203,918 Value ($000) $563 Avg Close — Range —
Q2 2018
Shares 205,585 Value ($000) $734 Avg Close — Range —
Q1 2018
Shares 109,815 Value ($000) $337 Avg Close — Range —
Q4 2017
Shares 72,524 Value ($000) $457 Avg Close — Range —
Q3 2017
Shares 47,051 Value ($000) $322 Avg Close — Range —
Q1 2017
Shares 15,337 Value ($000) $141 Avg Close — Range —
Q4 2016
Shares 31,595 Value ($000) $127 Avg Close — Range —
Q3 2016
Shares 41,680 Value ($000) $160 Avg Close — Range —
Q2 2016
Shares 67,302 Value ($000) $289 Avg Close — Range —
Q1 2016
Shares 109,193 Value ($000) $506 Avg Close — Range —
Q4 2015
Shares 249,067 Value ($000) $2,498 Avg Close — Range —
Q3 2015
Shares 20,758 Value ($000) $155 Avg Close — Range —
Q2 2015
Shares 9,712 Value ($000) $461 Avg Close — Range —
Q3 2014
Shares 15,867 Value ($000) $317 Avg Close — Range —
Q1 2014
Shares 26,943 Value ($000) $293 Avg Close — Range —
Q4 2013
Shares 27,446 Value ($000) $371 Avg Close — Range —